Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
EBIT MarginEBITDA MarginEBT MarginEquity AverageFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on EquityReturn on SalesTimes Interest Earned

Medicale (MCLE) Return on Equity (2021 - 2025)

Medicale (MCLE) has disclosed Return on Equity for 5 consecutive years, with 0.2% as the latest value for Q2 2025.

  • For the quarter ending Q2 2025, Return on Equity changed N/A year-over-year to 0.2%, compared with a TTM value of 0.2% through Jun 2025, changed N/A, and an annual FY2023 reading of 0.01%, down 9.0% over the prior year.
  • Return on Equity was 0.2% for Q2 2025 at Medicale, up from 0.18% in the prior quarter.
  • Across five years, Return on Equity topped out at 6.33% in Q3 2021 and bottomed at 0.01% in Q3 2023.
  • Average Return on Equity over 5 years is 0.74%, with a median of 0.16% recorded in 2025.
  • The sharpest move saw Return on Equity plummeted -628bps in 2022, then fell -6bps in 2023.
  • Year by year, Return on Equity stood at 1.2% in 2021, then crashed by -97bps to 0.04% in 2022, then crashed by -134bps to 0.01% in 2023, then soared by 1132bps to 0.14% in 2024, then skyrocketed by 41bps to 0.2% in 2025.
  • Business Quant data shows Return on Equity for MCLE at 0.2% in Q2 2025, 0.18% in Q1 2025, and 0.14% in Q4 2024.